A Phase I Study of S-3304 in Patients With Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 30 Apr 2018
At a glance
- Drugs S 3304 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Shionogi
- 24 Apr 2018 Status changed from active, no longer recruiting to completed.
- 19 Sep 2005 New trial record.